Respiratory Distress Syndrome: all 1,619 studies
Page 10 of 17. Open to participants first (319), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19CompletedNCT04390139Phase 1/2
- Predictors of Severe COVID-19 OutcomesCompletedNCT04388813
- Maneuver for Evaluating the Potential Recruitability of the Pulmonary Parenchyme in Patients With ARDSStatus unknownNCT04387669
- Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19.CompletedNCT04386720
- Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICUStatus unknownNCT04385004
- Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19Status unknownNCT04384731Phase 2
- Zofin (Organicell Flow) for Patients With COVID-19CompletedNCT04384445Phase 1/2
- Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19)CompletedNCT04383730
- Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress SyndromeCompletedNCT04383678
- Rehabilitation for People With COVID-19 in ICUCompletedNCT04381338Not applicable
- Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress SyndromeStatus unknownNCT04380935Phase 2/3
- A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other CausesCompletedNCT04378920Phase 1/2
- Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICUCompletedNCT04378582
- CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19WithdrawnNCT04378244Phase 1/2
- Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19)CompletedNCT04376905
- London's Exogenous Surfactant Study for COVID19CompletedNCT04375735Phase 1/2
- Human Ab Response & immunoMONItoring of COVID-19 PatientsCompletedNCT04373200Not applicable
- WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound.CompletedNCT04372680Not applicable
- MSCs in COVID-19 ARDSTerminatedNCT04371393Phase 3
- Pulmonary and Ventilatory Effects of Bed Verticalization in Patients With Acute Respiratory Distress SyndromeCompletedNCT04371016Not applicable
- Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19CompletedNCT04370249
- Prono Position and Mechanical PowerCompletedNCT04369105
- European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMOStatus unknownNCT04366921
- Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 InfectionNo longer availableNCT04366830
- Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress SyndromeStatus unknownNCT04366063Phase 2/3
- Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory DistressCompletedNCT04363463Not applicable
- Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 InfectionStatus unknownNCT04361903
- Pilot Study on Cytokine Filtration in COVID-19 ARDSStatus unknownNCT04361526Not applicable
- Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19TerminatedNCT04360096Phase 2/3
- Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 InfectionTerminatedNCT04359862Phase 4
- Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDSCompletedNCT04359290Phase 2
- Different PEEP Settings of COVID-19 Induced ARDSCompletedNCT04359251Not applicable
- Combined Lung Ultrasounds and Transthoracic Electrical Bioimpedance in Preterm Infants With Respiratory Distress.Status unknownNCT04359134
- Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19)CompletedNCT04358939Not applicable
- Dexmedetomidine to Improve Outcomes of ARDS in Critical Care COVID-19 PatientsStatus unknownNCT04358627
- Low Dose Morphine to Relieve Dyspnea in Acute Respiratory Failure (OPIDYS)CompletedNCT04358133Phase 2
- Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19CompletedNCT04357444Phase 2
- Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 InfectionTerminatedNCT04356443
- Sevoflurane in COVID-19 ARDS (SevCov)CompletedNCT04355962Phase 3
- SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19No longer availableNCT04355494
- Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE)TerminatedNCT04355364Phase 3
- Capnography Monitoring in Ventilated ChildrenStatus unknownNCT04354220
- Effect of PEEP Titration on the EELV Measured by the Nitrogen Dilution Technique in ARDSStatus unknownNCT04352725Not applicable
- Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress SyndromeCompletedNCT04351906Not applicable
- Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDSStatus unknownNCT04350710
- Polyvalent Immunoglobulin in COVID-19 Related ARdsCompletedNCT04350580Phase 3
- Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 PneumoniaCompletedNCT04349618Not applicable
- BAttLe Against COVID-19 Using MesenchYmal Stromal CellsSuspendedNCT04348461Phase 2
- Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19TerminatedNCT04347980Phase 3
- Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19)No longer availableNCT04346277
- Spironolactone in Covid-19 Induced ARDSCompletedNCT04345887
- Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19CompletedNCT04343404
- Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID)WithdrawnNCT04341285Not applicable
- Hemodynamic Characteristics of Patients With SARS-CoV-2CompletedNCT04337983
- Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2)Status unknownNCT04337190
- Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection DiseaseTerminatedNCT04335786Phase 4
- LIBERATE Trial in COVID-19WithdrawnNCT04334629Phase 4
- Non-invasive Neurally Adjusted Ventilator Assist or Continuous Positive Airway Pressure in Preterm InfantsCompletedNCT04333563Not applicable
- Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDSCompletedNCT04333368Phase 1/2
- Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDSStatus unknownNCT04331613Phase 1/2
- Lung Ultrasound to Guide Surfactant TherapyCompletedNCT04330443Not applicable
- Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19TerminatedNCT04327505Phase 2/3
- COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil IIITerminatedNCT04327401Phase 3
- The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated PneumoniaCompletedNCT04325685Not applicable
- Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19TerminatedNCT04325061Phase 4
- Neonatal Cardio-Pulmonary Outcome MeasureCompletedNCT04324957
- The Efficacy of Different Anti-viral Drugs in COVID 19 Infected PatientsStatus unknownNCT04321616Phase 2/3
- Complications Related to Transpulmonary ThermodilutionStatus unknownNCT04319965
- Evaluation of Von Willebrand Factor as a Marker For Early Diagnosis of Acute Respiratory Distress Syndrome (A.R.D.S) in Comparison to Interleukin 6 [IL-6]Status unknownNCT04317469
- Mechanisms for Organ Dysfunction in Covid-19CompletedNCT04316884
- Surfactant Nebulization for the Early Aeration of the Preterm LungCompletedNCT04315636Phase 3
- Adverse Events Related to Treatments Used Against Coronavirus Disease 2019CompletedNCT04314817
- A Low-Resource Oxygen Blender Prototype for Use in Modified Bubble CPAP CircuitsCompletedNCT04311320Not applicable
- Personalised Simulation Technologies for Optimising Treatment in the Intensive Care UnitCompletedNCT04297397
- High Flow Nasal Cannula in Immunocompromised Patient With Acute Respiratory FailureStatus unknownNCT04293991Not applicable
- Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress SyndromeCompletedNCT04289194Phase 1/2
- Prone Position and Renal Resistive IndexCompletedNCT04286490Not applicable
- Advisory Lead ARDS Respirator ManagementCompletedNCT04274296
- RENOVATE Fibrosis:HFNC Versus NIPPV in Acute Respiratory Failure in Patients With Pulmonary FibrosisTerminatedNCT04253405Not applicable
- Comparison of Different PEEP Titration Strategies Using Electrical Impedance Tomography in Patients With ARDSCompletedNCT04247477Not applicable
- Feasibility of Uninterrupted Infant Respiratory Support TreatmentCompletedNCT04244890
- PEEP and Spontaneous Breathing During ARDSCompletedNCT04241874Not applicable
- High Flow Nasal Cannula Versus Nasal Continuous Positive Airway Pressure for Respiratory Support of Preterm NeonatesCompletedNCT04238273
- SEvoflurane for Sedation in ARdsCompletedNCT04235608Phase 3
- Early PReserved SPONtaneous Breathing Activity in Mechanically Ventilated Patients With ARDS (PReSPON)Status unknownNCT04228471Not applicable
- Cardiometry Versus Fluid and Catheter Treatment Trial (FACTT Lite) on Fluid Management in Acute Respiratory Distress Syndrome PatientsCompletedNCT04219150Not applicable
- Early Caffeine and LISA Compared to Caffeine and CPAP in Preterm InfantsCompletedNCT04209946Not applicable
- Breathing Pattern, WOB and Gas Exchange in Patients With Acute Respiratory Distress Syndrome During the Spontaneous Breathing TrialStatus unknownNCT04209270
- Impact of the Transpulmonary Pressure on Right Ventricle Function in Acute Respiratory Distress SyndromeCompletedNCT04184674Not applicable
- Telemedicine in the Generals Practitioners OfficeStatus unknownNCT04168554
- The Role of Morphological Phenotype in ARDSCompletedNCT04157946
- Airway Pressure Release Ventilation for Moderate-to-severe Acute Respiratory Distress SyndromeCompletedNCT04156438Not applicable
- Acute Kidney Injury in Patients With Acute Respiratory Distress SyndromeCompletedNCT04154007
- Predictors of Intracranial Hemorrhage in ARDS Patients on ECMOStatus unknownNCT04142775
- Hemodynamic Effects of Changes in Transpulmonary Pressure During Recruitment Maneuver in Patients Under Pressure Supported Mechanical VentilationWithdrawnNCT04141293Not applicable
- Early Use of Prone Position in ECMO for Severe ARDSCompletedNCT04139733
- Pulmonary Microbiota and ARDS MortalityStatus unknownNCT04133558
- LISA vs INSURE in the Treatment of Respiratory Distress Syndrome in Preterm InfantsStatus unknownNCT04126382Phase 2
- Value of Diaphragmatic Motion Measurement at Ultrasonography to Predict Poor Prognosis in Emergency Department Patients With Acute Respiratory FailureCompletedNCT04119505
- Ventilator Weaning Outcome Between NIV-NAVA and Nasal CPAP (or IMV ) Modes in Premature NeonatesStatus unknownNCT04118400